Watch CBS News

Dupuis Diagnosed With Blood Clot In Lung, Out 6 Months

PITTSBURGH (KDKA) – The Pittsburgh Penguins will be without Pascal Dupuis for six months because of a blood clot in his lung.

According to a statement from the team, the clot was found during testing on Monday.

"Pascal had a blood clot in his leg that traveled to his lung," Penguins team physician Dr. Dharmesh Vyas said in a statement. "In medical terms, that is a deep vein thrombosis resulting in a pulmonary embolism. This is the second such incident that we know of for Pascal. The treatment is at least six months of blood thinners, during which time he will not be able to play hockey. Other than that, his condition is stable."

It was also revealed that Dupuis was diagnosed with a blood clot back in January, while recovering from a torn ACL.

Dupuis said the feeling he had this week was exactly the same as what he experienced in January. For now, hockey will take a backseat as he focuses on recovering and his family.

"It's not a great situation to be in, but that's the cards I've been dealt. Hockey is definitely second on my mind right now," Dupuis said.

Last season, Dupuis suffered a season-ending knee injury in a game against the Ottawa Senators on Dec. 23, 2013.

As for what the Penguins' will do to fill Dupuis' void on the roster, Associate General Manager Jason Botterill said they will eventually place him on the long-term injured reserve list to free up cap space.

At that time, they will hold front office meetings with scouts to determine a course of action.

Last year, goaltender Tomas Vokoun missed the entire season because of a blood clot in his pelvis.

You can follow Casey Shea on Twitter at http://twitter.com/sheavedice

Stay With KDKA.com For More Details
You May Also Be Interested In These Latest Sports Stories

Join The Conversation On The KDKA Facebook Page
Stay Up To Date, Follow KDKA On Twitter

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.